Influence of dialysis modality on renal transplant complications and outcomes

Clinical Nephrology

Volumn 72, Issue 1, 2009, Pages 62-68

  Yang, Q ^a   Zhao, S ^a   Chen, W ^a   Mao, H ^a   Huang, F ^a   Zheng, Z ^a   Chen, L ^a   Fei, J ^a   Yu, X ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Complications; Hemodialysis; Peritoneal dialysis; Renal transplant; Survival rate

Indexed keywords

CYCLOSPORIN A; DACLIZUMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DELAYED GRAFT FUNCTION; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEMODIALYSIS; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PERITONEAL DIALYSIS; POSTOPERATIVE CARE; PREOPERATIVE CARE; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT DURATION; ADOLESCENT; ANALYSIS OF VARIANCE; CHI SQUARE DISTRIBUTION; CHINA; GRAFT REJECTION; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; RENAL REPLACEMENT THERAPY; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 70349237829     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp72062     Document Type: Article

References (12)

1. Cancarini GC, Sandrini S, Setti G et al. Transplantation outcome in patients on PD and HD. Contrib Nephrol. 2006; 150: 259-270.
2. Carrilho FJ, Moraes CR, Pinho JR et al. Hepatitis B virus infection in Haemodialysis Centres from Santa Catarina State, Southern Brazil. Predictive risk factors for infection and molecular epidemiology. BMC Public Health. 2004; 27: 4-13.
3. Griveas I, Visvardis G, Sakellariou G et al. Biocompatibility study based on differential sequestration kinetics of CD14+CD16+ blood monocyte subsets with different dialyzers. Renal Fail. 2006; 28: 493-499.
4. Helal I, Abderrahim E, Ben Hamida F et al. Impact of dialysis modality on posttransplantation results in kidney transplantation. Transplantation Proc. 2007; 39: 2547-2549.
5. Joseph JT, Jindal RM. Influence of dialysis on posttransplant events. Clin Transplantation. 2002; 16: 18-23.
6. Keith DS, Cantarovich M, Paraskevas S et al. Duration of dialysis pretransplantation is an important risk factor for delayed recovery of renal function following deceased donor kidney transplantation. Transplant Int. 2008; 21: 126-132.
7. Passalacqua JA, Wiland AM, Fink JC et al. Increased incidence of postoperative infections associated with peritoneal dialysis in renal transplant recipients. Transplantation. 1999; 68: 535-540.
8. Pawlak K, Pawlak D, Mysliwiec M. Method of dialysis therapy and selected markers of oxidative stress and endothelial injury in patients with chronic renal failure. Pol Arch Med Wewn. 2005; 113: 21-26.
9. Pérez-Flores I, Sánchez-Fructuoso A, Calvo N et al. Pre-emptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list. Transplantation Proc. 2007; 39: 2123-2124.
10. Sela S, Shurtz-Swirski R, Shapiro G et al. Oxidative stress during hemodialysis: effect of heparin. Kidney Int. 2001; (Suppl) 78: S159-163.
11. Van Biesen W, Vanholder R, Van Loo A et al. Peritoneal dialysis favorably influences early graft function after renal transplantation compared to hemodialysis. Transplantation. 2000; 69: 508-514.
12. Wong PN, Fung TT, Mak SK et al. Hepatitis B virus infection in dialysis patients. J Gastroenterol Hepatol. 2005; 20: 1641-1651.